The Relationship of Serum levels of Vascular Endothelial Growth ...

2 downloads 0 Views 1MB Size Report
1- Assistant Professor of Internal Medicine, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran ... Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of ... E-mail: A.Amirkhosravi@kmu.ac.ir).
JKMU Journal of Kerman University of Medical Sciences, 2017; 24(3): 184-189

The Relationship of Serum levels of Vascular Endothelial Growth Factor with Disease Severity and the Number of Exacerbations in COPD Patients Seyed-Mehdi Hashemi-Bajgani, M.D.1, Mitra Samareh Fekri, M.D.2, Hadi Zeydabadi, M.D.3, Mohammad Rahmatian, M.Sc.4, Arian Amirkhosravi, Ph.D.5 1- Assistant Professor of Internal Medicine, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran 2- Associate Professor of Pulmonology, Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran 3- General Practitioner, Afzalipour Hospital Research Center, Kerman University of Medical Sciences, Kerman, Iran 4- Master of Nursing, Vice-Chancellor for Curative Affairs, Kerman University of Medical Sciences, Kerman, Iran 5- Department of Pharmacology & Toxicology, School of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran (Corresponding author; E-mail: [email protected]) Received: 23 August, 2016

Original article Vascular Endothelial Growth Factor (VEGF) COPD Severity Exacerbation

Accepted: 25 January, 2017

Chronic Obstructive Pulmonary Disease (COPD) is a chronic lung disease characterized by progressive and irreversible obstruction of the airways of the lungs. Different studies have emphasized on the role of Vascular Endothelial Growth Factor (VEGF) in COPD patients. The aim of this study was to investigate the relationship of this factor with disease severity and the number of exacerbations in COPD patients. This study is a Cross-sectional study on patients with chronic obstructive pulmonary disease referred to Besat clinic in Kerman in 2013-2014. After performing spirometery and confirming COPD diagnosis by a pulmonologist and obtaining consent form patients, blood samples were taken and level of VEGF was measured by ELISA method. Mean serum level of VEGF in patients was 160±156.6 µg/ml. More disease severity was associated with higher level of VEGF, but this association was not significant. No relationship was found between the number of exacerbations and VEGF level. The results of our study showed that serum levels of VEGF increases in COPD patients, but there is not a significant correlation between serum levels of VEGF and the severity of the disease and the number of exacerbations.

Introduction

184

Journal of Kerman University of Medical Sciences

2017, Vol. 24, Issue 3

Sampling



Statistical analysis

Results

Methods Study population

185

VEGF in COPD patients…

Hashemi-Bajgani, et al

27 23 18

8

Figure 1. The frequency distribution of patients based on the disease severity

32

16 12 8

8

Figure 2. The frequency distribution of patients based on the number of exacerbations

186

Journal of Kerman University of Medical Sciences

2017, Vol. 24, Issue 3

201.56 180.96 144.11

Disease severity Figure 3. Serum VEGF levels based on the disease severity

Discussion and Conclusion

187

217.63

VEGF in COPD patients…

Hashemi-Bajgani, et al

References

188

Journal of Kerman University of Medical Sciences

2017, Vol. 24, Issue 3

189